Bliss GVS Pharma informs about board meeting

29 Oct 2025 Evaluate

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bliss GVS Pharma has informed that a meeting of the Board of Directors of the Company will be held on Thursday, November 06, 2025 at the registered office of the Company to consider and approve, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025. Further, according to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Internal Procedures and Conduct for Regulating, Monitoring, and Reporting of Trading by Designated Persons, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from October 01, 2025, and shall remain closed till 48 hours after the announcement/declaration of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025. This intimation is also being uploaded on the Company's website at http://www.blissgvs.com/.

The above information is a part of company’s filings submitted to BSE. 

Bliss GVS Pharma Share Price

142.75 -1.40 (-0.97%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×